← Signals · Healthcare · TSX
$LABS
MediPharm Labs Corp.
Signal as of N/A  ·  90-day rolling window  ·  Pharmaceuticals
Confluence Score
—
out of 100  ·  Full breakdown →
Score delayed 7 days on Free  ·  See today's score — Analyst →
Signals scoring 20–39 have historically hit 47% of the time (avg +6.8% over 90 days, 105 backtested signals). Methodology →
🔒 Risk monitoring — insider-selling & reversal warnings (Analyst)
1 open-market buy  ·  1 unique buyer  ·  $13K total Lobbying: 0 regs  ·  Contracts: 0 wins
📅 Buying into earnings — Aug 13 (35d)
Confluence Score
—
Unlock breakdown →
Insider Activity (90d)
1
1 buyer  ·  $13K  ·  open-market only
Current Price
$0.07
CAD  ·  5-min cache
Market Cap
$30M
CAD  ·  TMX
Lobbying & Contracts
None
0 regs  ·  0 contracts
Healthcare on Form55: 43% hit rate · -5.4% alpha vs XIU.TO · 21 closed signals Track Record →
★
Signal Analyst
The Confluence Score and insider trade feed above are free. Signal Analyst adds the full component breakdown, lobbying registrations, and contract wins — plus alerts when this company's signal moves, so you don't have to keep checking back.
Monitor — CAD $29/mo
Price Chart
12 months daily  ·  TSX:LABS
Insider Transactions
90-day window  ·  13 filings
Date Insider Role Nature Dir. Shares Buy Price Return Value
Jun 09, 2026 Jameson, Emily — Exercise Sell 178,572 — — —
Jun 09, 2026 Jameson, Emily — Exercise Buy 98,214 — — —
Jun 09, 2026 Medland, John — Exercise Sell 160,715 — — —
Jun 09, 2026 Medland, John — Exercise Buy 88,393 — — —
Jun 09, 2026 Halyk, Christopher John — Exercise Sell 178,571 — — —
Jun 09, 2026 Halyk, Christopher John — Exercise Buy 98,214 — — —
Jun 09, 2026 Pidduck, David — Exercise Sell 604,286 — — —
Jun 09, 2026 Pidduck, David — Exercise Buy 302,142 — — —
Jun 09, 2026 Taves, Christopher David — Exercise Sell 392,857 — — —
Jun 09, 2026 Taves, Christopher David — Exercise Buy 392,857 — — —
Jun 09, 2026 Taves, Christopher David — Open Market Buy 176,786 $0.07 -6.7%  · 30d $13K
Jun 09, 2026 Hunter, Gregory Edison — Exercise Sell 366,429 — — —
Jun 09, 2026 Hunter, Gregory Edison — Exercise Buy 183,214 — — —
Score uses open-market buys only  ·  1 open-market  ·  6 plan / compensation shown but not scored  ·  Return is unrealized, to today's price; a “· Nd” mark means the 90-day window is still open (N of 90 days) — too early to judge.
Score Breakdown
Signal Analyst  ·  $29/mo
Component Points Max Detail Weight
Conviction (unique buyers)  ✓ FREE PREVIEW 30 30 1 unique buyer (maximum conviction)
Buy/sell ratio 20 14% buys (1B / 6S)
Dollar value 25 $13K
Lobbying activity 15 None
Contract wins 10 None
Insider track record 10 No track record data
Private placements 8 None
Confluence bonus 10 None
Cluster timing (velocity) 10 No coordinated buying cluster detected
Buy/sell reversal pattern 8 No buy/sell reversal pattern
Total 0 100
Unlock Component Detail — CAD $29/mo
Buying Insiders
Open-market · 90 days · 1 unique buyer
Insider Credibility Hit Rate Avg 90d Return Trades (eval'd) Buy Value (90d) Last Buy
Taves, Christopher David — — — — $13K Jun 09, 2026
Credibility score: historical hit rate × avg 90d return × sample size. View full insider leaderboard →
Lobbying Registrations
OCL active  ·  none found
No active OCL lobbying registrations in the last 90 days. Analyst plan →
Government Contract Wins
90-day window  ·  none found
No government contract wins in the last 90 days. Analyst plan →
Private Placements
12 months  ·  Signal Analyst  ·  $29/mo
Private placement history, deal size, and lock-up expiry tracking. Analyst plan →
Indigenous Consultation
no records on file

No Indigenous consultation records on file for LABS.

SEDAR+ Filings
official filing registry
Form55 monitors SEDAR+ filing alerts and newswire announcements for Technical Reports and material changes. Search SEDAR+ →
Short Interest
CIRO  ·  Jun 30, 2026
Shares short
198,264
Net change
+409 (+0.2%)
History
Jun 30: 198,264
Jun 15: 197,855
May 31: 197,855
May 15: 265,751
Apr 30: 197,828
Apr 15: 212,355
Aggregate short position from CIRO's Consolidated Short Position Report (published twice monthly).
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.